Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ALKS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for Alkermes plc
(Updated on Mar 28, 2024)

Buy or Hold candidate since Mar 19, 2024 Loss -2.27% PDF

The Alkermes plc stock price fell by -0.661% on the last day (Thursday, 28th Mar 2024) from $27.25 to $27.07. During the last trading day the stock fluctuated 1.52% from a day low at $26.92 to a day high of $27.33. The price has been going up and down for this period, and there has been a -6.27% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -232 thousand shares and in total, 1 million shares were bought and sold for approximately $30.86 million.

The stock is at the lower part of a wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $26.79 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect Alkermes plc stock with a 90% probability to be traded between $26.94 and $32.84 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ALKS Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, March 26, 2024, and so far it has risen 1.08%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Alkermes plc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $27.20 and $28.76. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Alkermes plc stock

Alkermes plc finds support from accumulated volume at $27.05 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.410 between high and low, or 1.52%. For the last week, the stock has had daily average volatility of 1.87%.

Our recommended stop-loss: $25.43 (-6.05%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 2 days ago.)

Trading Expectations (ALKS) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Alkermes plc to open at $27.11, and during the day (based on 14 day Average True Range), to move between $26.32 and $27.82, which gives a possible trading interval of +/-$0.751 (+/-2.77%) up or down from last closing price. If Alkermes plc takes out the full calculated possible swing range there will be an estimated 5.55% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $27.05 (0.07%) than the resistance at $28.75 (6.21%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Alkermes plc stock A Buy?

Alkermes plc holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.844 Hold/Accumulate Unchanged

Predicted Opening Price for Alkermes plc of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$27.11 ( 0.135%) $27.07

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ALKS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 27.52 1.65 %
R2 27.36 1.07 %
R1 27.26 0.714 %
Current price: 27.07
Support S1 26.95 -0.443 %
S2 26.85 -0.80 %
S3 26.70 -1.38 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 32.56 20.28 %
R2 32.18 18.88 %
R1 28.75 6.21 %
Current price 27.07
Support S1 27.05 -0.0739%
S2 26.97 -0.369%
S3 26.94 -0.480%

FAQ

What is the symbol for Alkermes plc Stock and on which exchange is it traded?
The symbol for Alkermes plc is ALKS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Alkermes plc Stock?
Alkermes plc holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Alkermes plc Stock?
Alkermes plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Alkermes plc Stock.

What's the current price of Alkermes plc Stock?
As of the end of day on the 2024-03-28, the price of an Alkermes plc (ALKS) share was $27.07.

What is the 52-week high and low for Alkermes plc Stock?
The 52-week high for Alkermes plc Stock is $33.71 and the 52-week low is $22.01.

What is the market capitalization of Alkermes plc Stock?
As of the 2024-03-28, the market capitalization of Alkermes plc is 4.523B.

When is the next earnings date for Alkermes plc?
The upcoming earnings date for Alkermes plc is Apr 24, 2024.
Click to get the best stock tips daily for free!

About Alkermes plc

Alkermes plc Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL for the treatment of alcohol and prevention of opioid dependence; RISPERDAL CONSTA for the tre... ALKS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT